DHEA replacement therapy for human aging: a call for perspective

  • G. Valenti
Article
First Online:

Keywords

DHEA DMBA Dehydroepiandrosterone Dehydroepiandrosterone Sulfate Antiatherogenic Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Baulieu E.E. and Robel P.: Neurosteroids: a new brain function? J. Steroid Biochem. Mol. Biol. 37: 395–403, 1997.CrossRefGoogle Scholar
  2. 2.
    Ceresini G., Freddi M., Mazza S., Nizzoli V., Ablondi F., Valenti G.: Concomitant evaluation of dehydroepiandrosterone sulfate and gonadal steroids in both serum and cerebrospinal fluid from human male subjects: 79th Annual Meeting of the Endocrine Society- Abstracts Book, 1997 (in press).Google Scholar
  3. 3.
    Maiewska M.D.: Neurochemical, physiological and behavioral actions of neurosteroids: role in personality, learning, aging and disease. ISPNE, 26th Congress Proceedings, 51, 1995.Google Scholar
  4. 4.
    Robel P., Baulieu E.E.: Dehydroepiandrosterone (DHEA) is a neuroactive neurosteroid. In: Dehydroepiandrosterone (DHEA) and aging. Ann. NY Acad. Sci. 774: 82–110, 1995.PubMedCrossRefGoogle Scholar
  5. 5.
    Regelson W., Loria R., Kalimi M.: Dehydroepiandrosterone (DHEA) the mother steroid. I. Immunologic action. Ann. NY Acad. Sci. 719: 553–563, 1994.PubMedCrossRefGoogle Scholar
  6. 6.
    Lucas J.A., Ansar A.S., Casey L., Mac Donald P.C.: Prevention of autoantibody formation and prolonged survival in New Zealand Black/New Zealand White F1 mice fed dehydroepiandros-terone. J. Clin. Invest. 75: 2091–2093, 1985.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Daynes R.A., Araneo B.A., Ershler W.B., Maloney C., Li G., Ryu S.: Altered regulation of IL-6 production with normal aging. J. Immunol. 150: 5219–5230, 1993.PubMedGoogle Scholar
  8. 8.
    Khorram O., Vu L., Yen S.C.: Activation of immune function by Dehydroepiandrosterone (DHEA) in age-advanced men. J. Gerontol. 52A, 1, M1–M7, 1997.CrossRefGoogle Scholar
  9. 9.
    Barrou Z., Charru P., Lidy C.: Dehydroepiandrosterone (DHEA) and aging. Arch. Gerontol. Geriatr. 24: 233–241, 1997.PubMedCrossRefGoogle Scholar
  10. 10.
    Szathmari M.: Dehydroepiandrosterone sulphate in the diagnosis of osteoporosis. Acta Biomed. Ateneo Parmense 66: 139–146, 1995.Google Scholar
  11. 11.
    Morales A.J., Nolan J.J., Nelson J.C., Yen S.S.C.: Effects of replacement dose of Dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrinol. Metab. 78: 1360–1367, 1994.PubMedGoogle Scholar
  12. 12.
    Barrett-Connor E., Khaw K., Yen S.S.C.: A prospective study of DS, mortality and cardiovascular disease. N. Engl. J. Med. 315:1519-1524, 1986.Google Scholar
  13. 13.
    Nafziger A.N., Herrington D.M., Bush T.L.: Dehydroepiandroster-one and Dehydroepiandrosterone sulphate: their relationship to cardiovascular disease. Epidemiol. Rev. 13: 267–274, 1991.PubMedGoogle Scholar
  14. 14.
    Nestler J.E., Barlascini C.O., Clore J.N., Blackward W.G.: Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensivity in normal men. J. Clin. Endocrinol. Metab. 66: 57–61, 1988.PubMedCrossRefGoogle Scholar
  15. 15.
    Denti L., Pasolini G., Ablondi F., Valenti G.: Correlation between plasma lipoprotein Lp(a) and sex hormone concentrations: a cross-sectional study in healthy males. Horm. Metab. Res. 26: 602–608, 1994.PubMedCrossRefGoogle Scholar
  16. 16.
    Mortola J.F., Yen S.S.C.: The effects of oral Dehydroepiandros-terone on endocrine-metabolic parameters in postmenopausal women. J. Clin. Endocrinol. Metab. 71: 696–704, 1990.PubMedCrossRefGoogle Scholar
  17. 17.
    Gordon G.B., Bush D.E., Weisman H.F.: Reduction of atherosclerosis by administration of Dehydroepiandrosterone. J. Clin. Invest. 82: 712–720, 1988.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Jesse R.L., Loesser K., Eich D.M., Quian Y.Z., Hess M.L., Nestler J.E.: Dehydroepiandrosterone inhibits human platelet aggregation in vitro and in vivo. Ann. NY Acad. Sci. 774: 281–286, 1995.PubMedCrossRefGoogle Scholar
  19. 19.
    Barbagallo M., Shan J., Pang P.K., Resnick L.M.: Effects of Dehydroepiandrosterone sulphate on cellular calcium responsiveness and vascular contractility. Hypertension 26: 1065, 1995.PubMedCrossRefGoogle Scholar
  20. 20.
    Zumoff B. Levin J., Rosenfeld R.S., Markham M., Strain G.W., Fukushima D.K.: Abnormal 24-hour mean plasma concentrations Dehydroepiandrosterone and Dehydroepiandrosterone sulfate in women with primary operable breast cancer. Cancer Res. 41: 3360–3363, 1981.PubMedGoogle Scholar
  21. 21.
    Schulz S., Klann R.C., Schonfeld S., Nyce J.W.: Mechanism of cell growth inibhition and cell arrest in human colonic adeno-carcinoma cells by Dehydroepiandrosterone: role of isoprenoid byosynthesis. Cancer Res. 52: 1372–1376, 1992.PubMedGoogle Scholar
  22. 22.
    Pashko L.L., Rovito R.J., Williams J.R., Sobel E.L., Schwartz A.G.: Dehydroepiandrosterone (DHEA) and 3-beta-methylan-drost-5-en-17-one. Inhibitors of 7,12-dimethylbenz-[a]anthracene (DMBA)-initiated and 12-0-tetradecanoylphorbol -13 -acetate (TPA) promoted skin papilloma formation in mice. Carcinogen-esis 5: 463–470, 1984.CrossRefGoogle Scholar
  23. 23.
    Regelson W., Kalimi M.: Dehydroepiandrosterone (DHEA) the multifunctional steroid. II Effects on the CNS, cell proliferation, metabolic and vascular, clinical and other effects. Mechanism of action? Ann. NY Acad. Sci. 719: 553–563, 1994.PubMedCrossRefGoogle Scholar
  24. 24.
    Casson P.R., Straughn A.B., Umstot E.S., Abraham G.E., Carson S.A., Buster J.E.: Delivery of Dehydroepiandrosterone to pre-menopausal women: effects of micronization and nonoral administration. Am. J. Obstet. Gynecol. 174: 649–653, 1996.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Internal Publishing Switzerland 1997

Authors and Affiliations

  • G. Valenti
    • 1
  1. 1.University of Parma Ospedale G. StuardParmaItaly

Personalised recommendations